Virginia Economic Review
This issue of Virginia Economic Review goes in depth on Virginia’s recent streak of high-profile biopharma manufacturing announcements, along with the investments and decisions that led the Commonwealth to the forefront of the industry. Article highlights include:
- Inside Virginia’s Rise to Biopharma Prominence
- Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
- Continuous Improvement: Virginia Strengthens Position as Global Leader in Crucial Manufacturing Technology
- Enabling Innovation
- Behind the Rise of a Research Center in Roanoke
- Merck’s Elkton Growth From ‘Vitamin Valley’ Beginnings
- Dulles Prepares for Pharma Growth Through Brussels Partnership
- Building a Sustainable Pharma Manufacturing Workforce
Past Issues
Fourth Quarter 2025
This issue takes an in-depth look at Virginia’s talent infrastructure and the ways the Commonwealth invests in its workforce.
Third Quarter 2025
This issue takes an in-depth look at Virginia’s infrastructure and the investments the Commonwealth makes to improve it.
Second Quarter 2025
This issue celebrates all of the unique factors that contribute to Virginia’s unbeatable quality of life.
Podcasts
The Urgency of Building Healthier Communities
April 1, 2026
A Conversation With Pam Cheng, Executive Vice President of Global Operations and IT and Chief Sustainability Officer, AstraZeneca
The History and Future of Pharmaceutical Manufacturing in Virginia
April 1, 2026
A Conversation With Dave Maraldo, Senior Vice President of Human Health Manufacturing Operations, Merck
Putting Talent in the Right Place
January 5, 2026
A Conversation With Peter Beard, Vice President of Policy and Programs, U.S. Chamber of Commerce Foundation